Cargando…

Tuberculosis vaccine development: from classic to clinical candidates

Bacillus Calmette-Guérin (BCG) has been in use for nearly 100 years and is the only licensed TB vaccine. While BCG provides protection against disseminated TB in infants, its protection against adult pulmonary tuberculosis (PTB) is variable. To achieve the ambitious goal of eradicating TB worldwide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junli, Zhao, Aihua, Tang, Jun, Wang, Guozhi, Shi, Yanan, Zhan, Lingjun, Qin, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223099/ https://www.ncbi.nlm.nih.gov/pubmed/32060754 http://dx.doi.org/10.1007/s10096-020-03843-6

Ejemplares similares

Whole Genome and Transcriptome Sequencing of Two Multi-Drug Resistant Mycobacterium tuberculosis Strains to Facilitate Illustrating Their Virulence in vivo
por: Tang, Jun, et al.
Publicado: (2020)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
por: Li, Junli, et al.
Publicado: (2021)

Animal Models for Tuberculosis in Translational and Precision Medicine
por: Zhan, Lingjun, et al.
Publicado: (2017)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
por: Li, Junli, et al.
Publicado: (2022)

Unmethylated CpG motif-containing genomic DNA fragment of Bacillus calmette-guerin promotes macrophage functions through TLR9-mediated activation of NF-κB and MAPKs signaling pathways
por: Li, Junli, et al.
Publicado: (2019)

Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection
por: Zhan, Lingjun, et al.
Publicado: (2016)

DnaJ, a promising vaccine candidate against Ureaplasma urealyticum infection
por: Guo, Fangyi, et al.
Publicado: (2022)

Toll-Like Receptor 8 Agonist Strengthens the Protective Efficacy of ESAT-6 Immunization to Mycobacterium tuberculosis Infection
por: Tang, Jun, et al.
Publicado: (2018)

Development of Mycobacterium tuberculosis attenuated strains as live vaccine candidates for tuberculosis
por: Villela, Anne, et al.
Publicado: (2014)

Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice
por: Li, Junli, et al.
Publicado: (2023)

Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
por: Li, Junli, et al.
Publicado: (2022)

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
por: Zhou, Fangbin, et al.
Publicado: (2023)

Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis
por: Flores-Valdez, Mario Alberto, et al.
Publicado: (2022)

Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus
por: Li, Junli, et al.
Publicado: (2022)

The Subunit AEC/BC02 Vaccine Combined with Antibiotics Provides Protection in Mycobacterium tuberculosis-Infected Guinea Pigs
por: Guo, Xiaonan, et al.
Publicado: (2022)

Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
por: Jelsma, Tinka, et al.
Publicado: (2021)

Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine
por: Stylianou, Elena, et al.
Publicado: (2018)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
por: Villarreal-Ramos, Bernardo, et al.
Publicado: (2014)

Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model
por: Gomez, Mellissa, et al.
Publicado: (2022)

Generation and Efficacy of Two Chimeric Viruses Derived from GPE(−) Vaccine Strain as Classical Swine Fever Vaccine Candidates
por: Huynh, Loc Tan, et al.
Publicado: (2023)

Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs
por: Guan, Qing, et al.
Publicado: (2020)

Immunogenicity and Safety of the M72/AS01(E) Candidate Vaccine Against Tuberculosis: A Meta-Analysis
por: Ji, Zhenhua, et al.
Publicado: (2019)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Consumption (Tuberculosis) in Classical Antiquity
por: Meinecke, Bruno
Publicado: (1927)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
por: Harris, Stephanie A., et al.
Publicado: (2018)

Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis
por: Abay, Zhandos, et al.
Publicado: (2023)

Rational development of multicomponent mRNA vaccine candidates against mpox
por: Zhang, Rong-Rong, et al.
Publicado: (2023)

The Development of Classical Swine Fever Marker Vaccines in Recent Years
por: Li, Fangfang, et al.
Publicado: (2022)

Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination
por: Sable, Suraj B., et al.
Publicado: (2011)

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
por: Alghamdi, Saad, et al.
Publicado: (2020)

The Fusion Multistage Synthetic Peptides as the Best Candidates for New Tuberculosis Vaccine
por: Keikha, Masoud, et al.
Publicado: (2018)

ADAM17 is an essential attachment factor for classical swine fever virus
por: Yuan, Fei, et al.
Publicado: (2021)

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
por: Cicognola, Claudia, et al.
Publicado: (2016)

Classic and New Diagnostic Approaches to Childhood Tuberculosis
por: López Ávalos, Gladys Guadalupe, et al.
Publicado: (2012)

Tuberculosis revisted: classic imaging findings in childhood
por: Mahomed, Nasreen, et al.
Publicado: (2023)

Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
por: Brookes, Roger H., et al.
Publicado: (2008)

Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse Vaccinology
por: Monterrubio-López, Gloria P., et al.
Publicado: (2015)

Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis
por: Abay, Zhandos, et al.
Publicado: (2023)

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
por: Chen, Qi, et al.
Publicado: (2018)

Development of Paramyosin as a Vaccine Candidate for Schistosomiasis
por: Jiz, Mario A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6nqmfsc5i670s3829p8o4rv40s